Three Years After US Filing, Biocon’s Bevacizumab Remains Out Of Reach

Indian Firm Has Received CRL From FDA, Must Resolve Facility Observations

 
• By Dean Rudge
  
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products